Jordyn Silverstein

Title(s)HS Clinical Instructor, Medicine
SchoolMedicine
vCardDownload vCard

    Collapse Research 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Real-world clinical outcomes of Trastuzumab Deruxtecan in HER2-expressing ovarian and endometrial Cancer. Gynecol Oncol Rep. 2026 Aug; 66:102183. Silverstein J, Alomaja O, Chatram D, Hajiabbasi M, Shachar E, Tseng CH, Thaker S, Bardia A, Karlan B, Hendrickson AW, Konecny GE. PMID: 42621866; PMCID: PMC13487597.
      View in: PubMed   Mentions:
    2. Actionable biomarker co-expression in advanced ovarian cancer: folate receptor alpha expression and related markers. Int J Gynecol Cancer. 2026 Aug 06; 104893. Shachar EK, Silverstein J, Gornbein J, Salani R, Karlan BY, Chase DM. PMID: 42642279.
      View in: PubMed   Mentions:
    3. Optimizing a Hematology/Oncology Curriculum for Internal Medicine Residents: A Two-Institution Modified Delphi Study. J Cancer Educ. 2026 Jun 30. Silverstein JF, Huppert LA, Schwede M, Goglin S, Johnson TP, Babik JM, Brondfield S. PMID: 42380386.
      View in: PubMed   Mentions:    Fields:    
    4. Mirvetuximab Soravtansine Exposure and Incidence of Cataract Surgery. JAMA Netw Open. 2026 May 01; 9(5):e2614557. Silverstein JF, Smick A, Tsui E, Alomaja O, Johnson B, Tseng CH, Salani R, Slamon DJ, Chase DM, Konecny GE. PMID: 42166161; PMCID: PMC13195477.
      View in: PubMed   Mentions:    Fields:    
    5. Are patient factors associated with real-world antibody-drug conjugate outcomes in gynecologic cancers? Gynecol Oncol. 2026 06; 209:26-32. Shachar EK, Silverstein J, Kwan L, Salani R, Karlan BY, Chase DM. PMID: 42054783; PMCID: PMC13644882.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Oncofertility patterns after the overturn of Roe v. Wade. J Natl Cancer Inst. 2026 Apr 18. Baclig NV, Silverstein J, Shah V, Karlan B, Anand SR, Glaspy JA. PMID: 41999338.
      View in: PubMed   Mentions:    Fields:    
    7. irAE-GPT: leveraging large language models to identify immune-related adverse events in electronic health records and clinical trial datasets. EBioMedicine. 2026 May; 127:106227. Bejan CA, Wang M, Venkateswaran S, Bergmann EA, Hiles L, Xu Y, Chandler GS, Brondfield S, Silverstein J, Wright F, de Dios K, Kim DM, Mukherjee E, Krantz MS, Yao L, Johnson DB, Phillips EJ, Balko JM, Mohindra R, Quandt Z. PMID: 41951517; PMCID: PMC13174231.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Ocular Toxic Effects During Mirvetuximab Soravtansine Therapy. JAMA Oncol. 2026 Mar 01; 12(3):317-319. Haidar AJ, Chen A, Chen JL, Al-Hashimi S, Ghaffari RS, Fung S, Silverstein J, Konecny GE, Tsui E. PMID: 41481303; PMCID: PMC12761749.
      View in: PubMed   Mentions:    Fields:    
    9. Multicenter Interspecialty Consensus on Experimental Oncology Drug-Related Ocular Adverse Event Reporting. JAMA Ophthalmol. 2026 01 01; 144(1):62-68. Pasricha ND, Kim SK, Farooq AV, Lindgren ES, Yan R, Seitzman GD, Chan MF, Shantha JG, Skondra D, Jeng BH, Chamberlain WD, Colby KA, Goldstein DA, Sobrin L, Kim IK, Singh K, Chambers WA, Boyd WM, Silverstein J, Pohlmann PR, Lu J, Glencer AC, Huppert LA, Chien AJ, Rugo HS, Esserman LJ. PMID: 41343206; PMCID: PMC12679423.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Trastuzumab deruxtecan and the evolving role of human epidermal growth factor receptor 2-targeted antibody-drug conjugates in breast and ovarian cancer. Curr Opin Obstet Gynecol. 2026 Feb 01; 38(1):48-56. Thaker SK, Silverstein J, Konecny GE, Bardia A. PMID: 41461040.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Phase II study of the efficacy and safety of palbociclib in patients with recurrent ovarian cancer. Int J Gynecol Cancer. 2025 10; 35(10):102028. Konecny GE, Davidson TM, Lebreton CL, Marsh LA, Chetram DK, Atkinson HJ, Larson MC, Oberg AL, Abdelaal N, Silverstein J, Jatoi A, Washburn A, Burton J, Dowdy S, Zhang L, Hallberg D, Velculescu VE, Slamon DJ, Wahner-Hendrickson AE. PMID: 40839974.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    12. Mirvetuximab soravtansine in the ovarian cancer treatment landscape: influence of prior taxane exposure on outcomes. Int J Gynecol Cancer. 2025 10; 35(10):102016. Smick AH, Brennan L, Silverstein J, Salani R, Konecny G, Chase DM. PMID: 40916321.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Mirvetuximab soravtansine for the treatment of epithelial ovarian, fallopian tube, or primary peritoneal cancer. Future Oncol. 2025 Jul; 21(17):2143-2153. Silverstein J, Smick A, Johnson B, Konecny GE. PMID: 40501444; PMCID: PMC12239798.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. irAE-GPT: Leveraging large language models to identify immune-related adverse events in electronic health records and clinical trial datasets. medRxiv. 2025 Mar 06. Bejan CA, Wang M, Venkateswaran S, Bergmann EA, Hiles L, Xu Y, Chandler GS, Brondfield S, Silverstein J, Wright F, de Dios K, Kim D, Mukherjee E, Krantz MS, Yao L, Johnson DB, Phillips EJ, Balko JM, Mohindra R, Quandt Z. PMID: 40093199; PMCID: PMC11908319.
      View in: PubMed   Mentions: 1  
    15. Antibody-drug conjugates as targeted therapy for treating gynecologic cancers: update 2025. Curr Opin Obstet Gynecol. 2025 02 01; 37(1):5-15. Silverstein J, Karlan B, Herrington N, Konecny G. PMID: 39480912; PMCID: PMC11676621.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    16. Synchronous or metachronous breast and colorectal cancers in younger-than-average-age patients: a case series. Oncologist. 2024 09 06; 29(9):e1159-e1168. Silverstein J, Wright F, Stanfield D, Chien AJ, Wong JM, Park JW, Blanco A, Van Loon K, Atreya CE. PMID: 38856325; PMCID: PMC11379633.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. For the Long Haul: Management of Long-Term Survivors after Melanoma Systemic Therapy. Curr Oncol Rep. 2024 Jul; 26(7):804-817. Silverstein J, Goyal N, Tsai KK. PMID: 38780676.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Risk of Death Due to Pregnancy-Associated Cancers-More Questions Than Answers. JAMA Oncol. 2023 11 01; 9(11):1588-1589. Silverstein J, Van Loon K. PMID: 37733335.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Evaluating Survival After Hospitalization Due to Immune-Related Adverse Events From Checkpoint Inhibitors. Oncologist. 2023 10 03; 28(10):e950-e959. Silverstein J, Wright F, Wang M, Young A, Kim D, De Dios K, Brondfield S, Quandt Z. PMID: 37335906; PMCID: PMC10546826.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    20. A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa. Cancer Epidemiol Biomarkers Prev. 2023 10 02; 32(10):1411-1420. Van Loon K, Mmbaga EJ, Mushi BP, Selekwa M, Mwanga A, Akoko LO, Mwaiselage J, Mosha I, Ng DL, Wu W, Silverstein J, Mulima G, Kaimila B, Gopal S, Snell JM, Benz SC, Vaske C, Sanborn Z, Sedgewick AJ, Radenbaugh A, Newton Y, Collisson EA. PMID: 37505926; PMCID: PMC11578543.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    21. The radiologist's role in a multidisciplinary approach to cancer in pregnancy. Abdom Radiol (NY). 2023 05; 48(5):1605-1611. Harwin J, Jha P, Post A, Silverstein J, Van Loon K, Poder L. PMID: 36705722; PMCID: PMC10149443.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. The Implications of the Supreme Court Decision to Overturn Roe v Wade for Women With Pregnancy-Associated Cancers. JAMA Oncol. 2022 10 01; 8(10):1394-1395. Silverstein J, Van Loon K. PMID: 35951314.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    23. Invited Commentary: Role of the Radiologist in Pregnancy-associated Cancer. Radiographics. 2022 Sep-Oct; 42(5):E158-E159. Silverstein J, Van Loon K. PMID: 35839140.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. Multidisciplinary Management of Cancer During Pregnancy. JCO Oncol Pract. 2020 09; 16(9):545-557. Silverstein J, Post AL, Chien AJ, Olin R, Tsai KK, Ngo Z, Van Loon K. PMID: 32910882.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    25. Hormone receptor expression of colorectal cancer diagnosed during the peri-partum period. Endocr Connect. 2019 Aug; 8(8):1149-1158. Silverstein J, Kidder W, Fisher S, Hope TA, Maisel S, Ng D, Van Ziffle J, Atreya CE, Van Loon K. PMID: 31370007; PMCID: PMC6686950.
      View in: PubMed   Mentions: 3  
    Jordyn's Networks
    Concepts (69)
    Derived automatically from this person's publications.
    _
    Co-Authors (40)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _